Download PDF
Facial Plast Surg 2014; 30(01): 012-015
DOI: 10.1055/s-0033-1363763
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Topicals in Skin Rejuvenation: Prescription Topicals

Noëlle S. Sherber
1   Sherber + Rad, Northwest, Washington, District of Columbia
› Author Affiliations
Further Information

Publication History

Publication Date:
31 January 2014 (online)

Also available at
    Permissions and Reprints

Abstract

With the recent proliferation of over the counter cosmeceuticals, prescription topical skin treatments have the cache of being evidence-based and not being available outside the setting of a patient–physician interaction. In the setting of facial rejuvenation, patient demand for prescription topical skin treatments falls into three main roles: (1) stimulation of collagen production; (2) improvement of dyspigmentation; and (3) amelioration of adult acne.

Keywords

skin care - retinoids - glycolic acid - hydroquinone - antiaging
 

  • References

  • 1 Bernstein EF, Lee J, Brown DB, Yu R, Van Scott E. Glycolic acid treatment increases type I collagen mRNA and hyaluronic acid content of human skin. Dermatol Surg 2001; 27 (5) 429-433
    CrossrefPubMedGoogle Scholar
  • 2 Griffiths CEM, Russman AN, Majmudar G, Singer RS, Hamilton TA, Voorhees JJ. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 1993; 329 (8) 530-535
    CrossrefPubMedGoogle Scholar
  • 3 Griffiths CEM, Kang S, Ellis CN , et al. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams. Arch Dermatol 1995; 131 (9) 1037-1044
    CrossrefPubMedGoogle Scholar
  • 4 Bershad S, Kranjac Singer G, Parente JE , et al. Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol 2002; 138 (4) 481-489
    PubMedGoogle Scholar
  • 5 Matts PJ, Fink B. Chronic sun damage and the perception of age, health and attractiveness. Photochem Photobiol Sci 2010; 9 (4) 421-431
    CrossrefPubMedGoogle Scholar
  • 6 Ferreira Cestari T, Hassun K, Sittart A, de Lourdes Viegas M. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol 2007; 6 (1) 36-39
    CrossrefPubMedGoogle Scholar
  • 7 Nordlund JJ, Grimes PE, Ortonne JP. The safety of hydroquinone. J Eur Acad Dermatol Venereol 2006; 20 (7) 781-787
    CrossrefPubMedGoogle Scholar
  • 8 Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol 2011; 10 (6) 586-590
    PubMedGoogle Scholar
  • 9 Bissett DL, Oblong JE, Berge CA. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg 2005; 31 (7 Pt 2) 860-865 , discussion 865
    PubMedGoogle Scholar
  • 10 Draelos ZD, Carter E, Maloney JM , et al; United States/Canada Dapsone Gel Study Group. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol 2007; 56 (3) e1-e10
    CrossrefPubMedGoogle Scholar
  • 11 Tanghetti E, Harper JC, Oefelein MG. The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable. J Drugs Dermatol 2012; 11 (12) 1417-1421
    PubMedGoogle Scholar
  • 12 Harper JC. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel. J Drugs Dermatol 2012; 11 (12) 1440-1445
    PubMedGoogle Scholar